Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Malignant Melanoma

  Free Subscription

Articles published in Cutis

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    February 2024
  1. NGO BT
    Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality.
    Cutis. 2024;113:94-96.

    January 2024
  2. MANIACI JL, Raghavan SS
    PRAME Expression in Melanocytic Proliferations in Special Sites.
    Cutis. 2024;113:43-47.
    PubMed     Abstract available

    November 2023
  3. WHITE KD, Kerkvliet AM, Jassim AD
    Aberrant Expression of CD56 in Metastatic Malignant Melanoma.
    Cutis. 2023;112:E13-E15.

  4. SHAFI S, Challa B, Parwani AV, Aung TN, et al
    New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives.
    Cutis. 2023;112:E32-E39.
    PubMed     Abstract available

    September 2023
  5. BORMANN JL, Kerkvliet AM
    Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors.
    Cutis. 2023;112:E17-E20.

    May 2023
  6. SULLIVAN DY, Sakamoto GK
    Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma.
    Cutis. 2023;111:E13-E15.

  7. ANDERSON JM, Tejani I, Jarmain T, Kellett L, et al
    Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of Melanoma.
    Cutis. 2023;111:254-258.
    PubMed     Abstract available

  8. MASSON R, Kwong A, Chen A, Barajas G, et al
    Disparities in Melanoma Demographics, Tumor Stage, and Metastases in Hispanic and Latino Patients: A Retrospective Study.
    Cutis. 2023;111:245-246.

  9. NGO BT
    Gene Expression Profiling for Melanoma Prognosis: Going Beyond What We See With Our Eyes.
    Cutis. 2023;111:222-223.

  10. LOGAN S, Shinohara MM
    Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy.
    Cutis. 2023;111:E16-E17.

    April 2023
  11. KIPERS TG, Mullen HEK, Blumetti B
    Acute Onset of Vitiligolike Depigmentation After Nivolumab Therapy for Systemic Melanoma.
    Cutis. 2023;111:E15-E18.

    March 2023
  12. LY S, Rollins B, Mohr K, Jennings T, et al
    Hair Repigmentation as a Melanoma Warning Sign.
    Cutis. 2023;111:E18-E21.

    January 2023
  13. SABLE KA, Shields BE
    The Role of Dietary Antioxidants in Melanoma and Nonmelanoma Skin Cancer.
    Cutis. 2023;111:33-48.
    PubMed     Abstract available

    November 2022
  14. COKER HB 4TH, Mountcastle EA
    Primary Malignant Melanoma of the Middle Ear.
    Cutis. 2022;110:E12-E14.

    October 2022
  15. ALBERT NM, Gaddi A, Klawonn MA, Helm L, et al
    Genital Lentiginosis: A Benign Pigmentary Abnormality Often Raising Concern for Melanoma.
    Cutis. 2022;110:E36-E38.

    September 2022
  16. PATEL K, Sanchez IM, Nguyen JC, Chan LS, et al
    Disparities of Cutaneous Malignancies in the US Military.
    Cutis. 2022;110:132-136.
    PubMed     Abstract available

  17. LALLA SC, Kumar AB, Lehman JS, Lohse CM, et al
    Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A Population-Based Study.
    Cutis. 2022;110:150-154.
    PubMed     Abstract available

    August 2022
  18. SAX J, Lamerson C
    Ultra-Late Cutaneous Melanoma Recurrence Following 49 Years of Quiescence.
    Cutis. 2022;110:E53-E55.

    May 2022
  19. USATINE RP, Heath CR
    Cutis. 2022;109:284-285.

  20. HENRY W, Nash S, Pemberton J
    Conjunctival Melanoma of the Left Lower Eyelid.
    Cutis. 2022;109:E25-E27.

  21. KARAARSLAN I, Ozdemir F, Yaman B, Acar A, et al
    Reflectance Confocal Microscopy Findings in a Small-Diameter Invasive Melanoma.
    Cutis. 2022;109:269-271.
    PubMed     Abstract available

  22. HARVEY JA, Lehman JS, Lohse CM, Chamberlain AM, et al
    BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study.
    Cutis. 2022;109:279-283.
    PubMed     Abstract available

    June 2021
  23. FAWAZ B, Halpern A
    Nivolumab-Induced Granuloma Annulare.
    Cutis. 2021;107:E2-E4.
    PubMed     Abstract available

    May 2021
  24. STOKAR E, Rodriguez C, Feldman J
    Desmoplastic Melanoma Masquerading as Neurofibroma.
    Cutis. 2021;107:258-260.
    PubMed     Abstract available

  25. TSCHEN J, Davies P, Meek SM, Clarke LE, et al
    Clinical Use of a Diagnostic Gene Expression Signature for Melanocytic Neoplasms.
    Cutis. 2021;107:264-269.
    PubMed     Abstract available

    April 2021
  26. ELIAS ML, John AM, Maddukuri S, Schwartz RA, et al
    Treatment Delay in Melanoma: A Risk Factor Analysis of an Impending Crisis.
    Cutis. 2021;107:E19-E26.
    PubMed     Abstract available

  27. KORNREICH D, Saedi N
    Home Treatment of Presumed Melanocytic Nevus With Frankincense.
    Cutis. 2021;107:E56-E57.

    January 2021
  28. GALL R, Bongiorno M, Handfield K
    Skin cancer in the US Military.
    Cutis. 2021;107:29-33.
    PubMed     Abstract available

    November 2020
  29. HAMIDI S, Kim GH, DeClerck BK
    Multiple glomangiomas in a patient with a history of metastatic melanoma.
    Cutis. 2020;106:E20-E22.

    January 2020
  30. CONDIE D, Fathi R, Nijhawan RI
    Cartilage sutures for a large nasal defect.
    Cutis. 2020;105:44-45.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.